PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-17.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
17.79%
EBIT growth below 50% of QRVO's 810.08%. Michael Burry would suspect deeper competitive or cost structure issues.
17.79%
Operating income growth above 1.5x QRVO's 6.61%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
40.61%
Positive net income growth while QRVO is negative. John Neff might see a big relative performance advantage.
36.36%
Positive EPS growth while QRVO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while QRVO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.67%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.15%
Dividend growth of 7.15% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-43.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-90.98%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-22.52%
Negative 10Y revenue/share CAGR while QRVO stands at 95.48%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-30.24%
Negative 5Y CAGR while QRVO stands at 27.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.27%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
23879.66%
10Y OCF/share CAGR above 1.5x QRVO's 108.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
98.23%
5Y OCF/share CAGR above 1.5x QRVO's 5.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-44.59%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
26.28%
Below 50% of QRVO's 1921.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
27.72%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
-166.64%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
283.66%
Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
154.84%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
78.94%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
-68.64%
Cut dividends over 10 years while QRVO stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
1.81%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
1.65%
3Y dividend/share CAGR of 1.65% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-16.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-8.73%
Negative asset growth while QRVO invests at 1.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.32%
We have a declining book value while QRVO shows 3.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.53%
We have some new debt while QRVO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-13.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-22.00%
We cut SG&A while QRVO invests at 19.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.